[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100604578":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":14,"responsibleParty":29,"collaborators":7,"id":33,"slug":7,"hasResults":34,"nctId":35,"briefTitle":36,"officialTitle":37,"acronym":38,"eligibilityCriteria":39,"healthyVolunteers":34,"sex":40,"minAge":41,"maxAge":7,"enrollmentInfo":42,"targetDuration":45,"studyType":46,"phases":7,"briefSummary":47,"conditions":48,"keywords":53,"overallStatus":17,"whyStopped":7,"lastUpdateSubmitDate":57,"lastUpdatePostDateStruct":58,"startDateStruct":61,"completionDateStruct":63,"leadSponsor":65,"locationsCount":66},{"fullName":5,"class":6},"University Hospital Schleswig-Holstein","OTHER",null,[9],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},"Laura K Sievers, MD","CONTACT","+49 431 500 23001","Laura.Rakow@uksh.de",[15],{"facility":16,"status":17,"city":18,"state":7,"zip":19,"country":20,"cosmosGeoPoint":21,"geoPoint":26,"contacts":27},"University Hospital Schleswig- Holstein","RECRUITING","Kiel","24105","Germany",{"type":22,"coordinates":23},"Point",[24,25],10.13489,54.32133,{"lat":25,"lon":24},[28],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},{"type":30,"investigatorFullName":31,"investigatorTitle":32,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"PRINCIPAL_INVESTIGATOR","Laura Katharina Sievers","Principal Investigator","100604578",false,"NCT07151339","Pilot Project Renal and Cardiovascular Tertiary Prevention in Preeclampsia","Pilotprojekt Renale Und kardiovaskuläre Tertiärprävention Nach Präeklampsie","EagleEye3P","Inclusion Criteria:\n\n* older than 18 yrs\n* diagnosed preeclampsia, HELLP syndrome or kidney disease durig pregnancy\n\nExclusion Criteria:\n\n* unable for informed consent","FEMALE","18 Years",{"count":43,"type":44},100,"ESTIMATED","12 Months","OBSERVATIONAL","Tertiary prevention program for women with preeclampsia, HELLP syndrome, kidney disease and pregnancy or associated conditions, including founding of a biobank. (Observational study since no interference with regular path of treatment suggested in national and international guidelines)",[49,50,51,52],"Preeclampsia","HELLP Syndrome","Eclampsia","Kidney Disease",[54,55,56],"cardiovascular prevention","preeclampsia","pregnancy","2025-08-28",{"date":59,"type":60},"2025-09-03","ACTUAL",{"date":62,"type":60},"2024-11-01",{"date":64,"type":44},"2030-11",{"name":5,"class":6},1]